Janux Therapeutics Inc (NASDAQ:JANX) price closed higher on Friday, May 03, jumping 3.76% above its previous close.
A look at the daily price movement shows that the last close reads $62.43. Taking into account the 52-week price action we note that the stock hit a 52-week high of $64.79 and 52-week low of $5.65. The stock added 82.99% on its value in the past month.
Janux Therapeutics Inc, which has a market valuation of $3.36 billion. Analysts tracking JANX have forecast the quarterly EPS to shrink by -0.33 per share this quarter, while the same analysts predict the annual EPS to hit -$1.35 for the year 2024 and up to -$1.64 for 2025. In this case, analysts estimate an annual EPS growth of -2.30% for the year and -21.50% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $760k, with the likely lows of -$ and highs of $2.2 million. The average estimate suggests sales growth for the quarter will likely fall by -62.90% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $2.76 million for the company’s annual revenue in 2024. Per this projection, the revenue is forecast to grow -65.90% below that which the company brought in 2024.
On the technical perspective front, indicators give JANX a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.
The overview shows that JANX’s price is at present 31.66% off the SMA20 and 52.76% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 80.74, with weekly volatility standing at 13.67%. The indicator jumps to 10.08% when calculated based on the past 30 days. Janux Therapeutics Inc (NASDAQ:JANX)’s beta value is holding at 3.87, while the average true range (ATR) indicator is currently reading 4.68.
An analysis of the Janux Therapeutics Inc (NASDAQ:JANX) stock in terms of its daily trading volume indicates that the 3-month average is 1.02 million.
Current records show that the company has 46.25M in outstanding shares. The insiders’ percentage holdings are 33.35% of outstanding shares while the percentage share held by institutions stands at 57.64%. But the 503.73% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
